JAN 11, 2021
Therapies for Ocular Genetic Disorders
1-Minute Video; AAO 2020 Virtual
Genetic Eye Diseases, Pediatric Ophth/Strabismus
In this 1-Minute Video, Dr. Arlene Drack discusses therapies for ocular genetic disorders. Congenital nystagmus, reduced night vision or decreased BCVA are clues for inherited eye disorders. She suggests genetic testing if the electroretinogram is abnormal, but recommends working with a genetic counselor or a genetic eye disease service, because the results can be hard to interpret. Patients with RPE65-related disease may benefit from Luxturna whereas individuals with other conditions may be able to find a clinical trial for their condition. It is important to tell patients that there is a lot of ongoing research for inherited retinal disorders and that more treatments will be available with time.
To learn more, watch Dr. Drack’s talk “Therapies for Ocular Genetics Disorders,” during the Pediatric Subspeciality Day session, “Now You See Me—Tell Me What to Do in Therapy for Ocular Genetic Disease" (PED06V).
Relevant Financial Disclosures: Dr. Drack receives grant support from the Chakraborty Family Foundation, NIH, Research to Prevent Blindness, Spark Therapeutics and Vision of Children. She also receives grant support from and is a consultant with ProQr, and grant support and lecturing fees from rerophin. In addition, she has patents/royalty with Novartis.